세계의 CBD 오일 및 CBD 컨슈머 헬스 시장 보고서(2025년)
CBD Oil And CBD Consumer Health Global Market Report 2025
상품코드 : 1824518
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

CBD 오일 및 CBD 컨슈머 헬스 시장 규모는 앞으로 수년간 비약적인 성장이 예상됩니다. 2029년 연평균 복합 성장률(CAGR)은 27.2%를 나타내 2,018억 1,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 국제시장 확대, 소비자교육 프로그램, 지속가능성의 중시의 고조, 헬스케어 전문가의 추천, 교육이니셔티브의 고조에 기인한다고 생각됩니다. 예측 기간의 주요 동향은 마이크로 도징, 반려동물 CBD 제품, CBD 음료, 건강 및 피트니스 통합, 칸나비노이드 조합 등입니다.

향후 5년간의 성장률 27.2%라는 예측은 이 시장의 전회 예측으로부터 0.5%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 이스라엘과 콜롬비아에서 공급되는 의약품 등급 칸나비디올(CBD) 단리물 및 나노에멀젼 기술 비용을 늘리고 소비자 제품 비용을 악화시키고 치료 접근을 제한함으로써 미국 웰빙 시장에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위하게 됩니다.

CBD를 배합한 제품과 관련된 건강상의 이점에 대한 의식 증가는 CBD 오일 및 CBD 컨슈머 헬스 시장 성장의 원동력이 되고 있습니다. CBD를 성분으로 포함한 제품에는 다양한 식품과 퍼스널케어 제품이 포함됩니다. CBD가 들어간 제품의 긍정적인 건강 효과에 대한 인식이 높아지면 칸나비디올 제품의 사용률이 높아지고 있습니다. 수면장애, 불안, 통증, 스트레스, 불쾌감 등의 문제를 해결하기 위해 개인은 CBD 오일에 눈을 돌리고 있습니다. 예를 들어, 2022년 3월 기준 미국에 본사를 둔 편의점과 연료 소매 협회인 미국 편의점 협회(National Association of Convenience Stores)의 보고서에 따르면 CBD의 주요 이점으로 꼽힌 것은 통증 완화입니다. 그러나 밀레니얼 세대는 정신위생상의 이점을 매우 중요시했고, 67%가 CBD가 불안에 도움이 될 것이라고 응답했고, 46%가 우울증의 완화에 효과가 있다고 응답했으며, 41%가 PTSD 증상의 개선을 보고했습니다. 그 결과 CBD가 들어간 제품의 건강 효과를 둘러싼 인지도의 향상이 CBD 오일 및 CBD 컨슈머 헬스 시장을 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

CBD (Cannabidiol), a non-psychoactive compound from cannabis sativa, is extracted and diluted with carrier oils such as hemp seed or coconut oil to produce CBD oil, used in dietary supplements for health benefits.

The primary categories in the CBD market consist of CBD oil and CBD consumer health products. CBD oil is utilized in treating various brain-related conditions such as anxiety, depression, epilepsy syndromes, PTSD, and substance addiction. Derived from the cannabis plant, cannabidiol (CBD) is extracted and blended with oils such as hemp seed or coconut oil to create CBD oil. These products find application in addressing issues related to anxiety, stress, sleep disorders, chronic pain, migraines, skincare, seizures, joint inflammation, neurological conditions, among others. CBD oil and consumer health products are distributed through various channels including B2B and B2C platforms for CBD oil, and online platforms, retail stores, and pharmacies for CBD consumer health products.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The CBD oil and CBD consumer health products market research report is one of a series of new reports from The Business Research Company that provides CBD oil and CBD consumer health products market statistics, including CBD oil and CBD consumer health products industry global market size, regional shares, competitors with a CBD oil and CBD consumer health products market share, detailed CBD oil and CBD consumer health products market segments, market trends and opportunities, and any further data you may need to thrive in the CBD oil and CBD consumer health products industry. This CBD oil and CBD consumer health products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cbd oil and cbd consumer health market size has grown exponentially in recent years. It will grow from $62.05 billion in 2024 to $77.14 billion in 2025 at a compound annual growth rate (CAGR) of 24.3%. The growth in the historic period can be attributed to legalization and regulatory changes, changing societal attitudes, e-commerce growth, expansion of retail channels, celebrity endorsements.

The cbd oil and cbd consumer health market size is expected to see exponential growth in the next few years. It will grow to $201.81 billion in 2029 at a compound annual growth rate (CAGR) of 27.2%. The growth in the forecast period can be attributed to international market expansion, consumer education programs, growing emphasis on sustainability, healthcare professional recommendations, rise in educational initiatives. Major trends in the forecast period include microdosing, pet CBD products, CBD-infused beverages, health and fitness integration, cannabinoid combinations.

The forecast of 27.2% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. wellness markets by driving up the cost of pharmaceutical-grade Cannabidiol(CBD) isolates and nanoemulsion technologies sourced from Israel and Colombia, exacerbating consumer product costs and limiting therapeutic access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in awareness regarding the health advantages associated with CBD-infused products is a driving force behind the growth of the CBD oils and CBD consumer health market. Products incorporating CBD as an ingredient include various food items and personal care products. The increasing recognition of the positive health effects of CBD-infused products is leading to a heightened usage of cannabidiol products. Individuals are turning to CBD oil to address issues such as sleep disturbances, anxiety, pain, stress, and discomfort. For instance, as of March 2022, reports from the National Association of Convenience Stores, a U.S.-based association for convenience and fuel retailing, revealed that the primary cited benefit of CBD is pain relief. However, millennials place significant importance on mental health benefits, with 67% stating that CBD helps with anxiety, 46% indicating its efficacy in alleviating depression, and 41% reporting improvements in PTSD symptoms. Consequently, the increased awareness surrounding the health benefits of CBD-infused products is propelling the CBD oils and CBD consumer health market.

The increasing demand for cannabidiol (CBD) in pharmaceutical formulations is expected to significantly drive the growth of the CBD oils and consumer health market in the future. Pharmaceutical formulation involves combining various chemical substances, including active drugs, to create a final medicinal product. The incorporation of CBD oil in these formulations ensures accurate and consistent delivery of CBD, which is essential for achieving therapeutic efficacy. For example, in July 2023, Releaf Dispensary Ltd, a UK-based medical clinic, reported that adults over 55 comprise approximately 31% of CBD users in the UK, spending an average of £24 ($30) monthly on CBD products. Furthermore, over 70% of consumers prefer using tinctures, oils, or capsules for their CBD intake. Thus, the growing demand for cannabidiol in pharmaceutical formulations is driving the expansion of the CBD oils and consumer health market.

Prominent players in the CBD oils and consumer health markets are directing their efforts toward the development of innovative products, notably premium pure cannabidiol (CBD) gummies, to maintain their market positions. These gummies are edible treats infused with high-quality CBD oil, a compound derived from the cannabis plant. For example, in May 2022, NextEvo Naturals, a reputable US-based premium supplement brand, introduced their NextEvo premium pure cannabidiol (CBD) gummies. These gummies feature hemp extract and contain 10 mg of their SmartSorb CBD, boasting vegan, non-GMO, and THC-free attributes. They stand out for their SmartSorb delivery technology, enabling rapid and enhanced absorption by transforming oil-soluble CBD into a water-soluble-such as emulsion. This innovation aims to provide consumers with a more efficient and effective means of experiencing the benefits of CBD.

Key players in the CBD oils and consumer health markets are strategically pursuing partnerships to deliver dependable services to their customers. These strategic partnerships involve collaborative arrangements between two or more companies or organizations, aimed at mutual benefit and the attainment of shared objectives. For instance, in November 2022, Kanabo Group PLC, a UK-based company focused on medical cannabis research and development, entered into a partnership with British Cannabis, the largest independent producer, manufacturer, and distributor of legal cannabis in the UK. This collaboration aims to supply CBD sourced from British Cannabis. Through the Treat It platform, physicians gain the ability to recommend CBD products from British Cannabis to their patients, facilitated by this agreement. Treat It serves as a secondary care organization leveraging a secure digital healthcare platform to connect individuals with medical specialists. Kanabo's objective is to enrich patients' quality of life by offering more accessible and cost-effective alternative pain management solutions, such as the products provided by British Cannabis. This strategic partnership enables both entities to leverage their strengths and expertise to better serve patients seeking CBD-based treatments.

In February 2022, Flora Growth Corp., a Canadian cannabis products manufacturer, completed the acquisition of JustCBD for an undisclosed sum. This acquisition is poised to bolster Flora's presence within the U.S. wellness market and pave the way for global expansion opportunities across Flora's diverse product lines. JustCBD, a US-based company, specializes in manufacturing CBD-infused products.

Major companies operating in the CBD oil and CBD consumer health market include Tilray Inc., Canopy Growth Corporation, Extract Labs, Aurora Cannabis Inc., Charlotte's Web Holdings Inc., Medical Marijuana Inc., PlusCBD Oil by CV Sciences, Green Roads, CBD American Shaman, Medterra CBD, Endoca BV, Bluebird Botanicals, CVSciences Inc., NuLeaf Naturals LLC, Lazarus Naturals, Isodiol International Inc, Lord Jones, HempMeds, JOY Organics, HempFusion Wellness Inc., Diamond CBD, Mary's Nutritionals, Elixinol LLC, HempLucid, Veritas Farms, Cibdol B.V., Ananda Hemp, Hemp Bombs, Highland Pharms, PharmaHemp

North America was the largest region in the CBD oil and CBD consumer health market share in 2024. The regions covered in the cbd oil and cbd consumer health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cbd oil and cbd consumer health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The CBD oils and CBD consumer health market consists of sales of CBD isolate and synthetic CBD. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CBD Oil And CBD Consumer Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cbd oil and cbd consumer health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cbd oil and cbd consumer health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cbd oil and cbd consumer health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. CBD Oil And CBD Consumer Health Market Characteristics

3. CBD Oil And CBD Consumer Health Market Trends And Strategies

4. CBD Oil And CBD Consumer Health Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global CBD Oil And CBD Consumer Health Growth Analysis And Strategic Analysis Framework

6. CBD Oil And CBD Consumer Health Market Segmentation

7. CBD Oil And CBD Consumer Health Market Regional And Country Analysis

8. Asia-Pacific CBD Oil And CBD Consumer Health Market

9. China CBD Oil And CBD Consumer Health Market

10. India CBD Oil And CBD Consumer Health Market

11. Japan CBD Oil And CBD Consumer Health Market

12. Australia CBD Oil And CBD Consumer Health Market

13. Indonesia CBD Oil And CBD Consumer Health Market

14. South Korea CBD Oil And CBD Consumer Health Market

15. Western Europe CBD Oil And CBD Consumer Health Market

16. UK CBD Oil And CBD Consumer Health Market

17. Germany CBD Oil And CBD Consumer Health Market

18. France CBD Oil And CBD Consumer Health Market

19. Italy CBD Oil And CBD Consumer Health Market

20. Spain CBD Oil And CBD Consumer Health Market

21. Eastern Europe CBD Oil And CBD Consumer Health Market

22. Russia CBD Oil And CBD Consumer Health Market

23. North America CBD Oil And CBD Consumer Health Market

24. USA CBD Oil And CBD Consumer Health Market

25. Canada CBD Oil And CBD Consumer Health Market

26. South America CBD Oil And CBD Consumer Health Market

27. Brazil CBD Oil And CBD Consumer Health Market

28. Middle East CBD Oil And CBD Consumer Health Market

29. Africa CBD Oil And CBD Consumer Health Market

30. CBD Oil And CBD Consumer Health Market Competitive Landscape And Company Profiles

31. CBD Oil And CBD Consumer Health Market Other Major And Innovative Companies

32. Global CBD Oil And CBD Consumer Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The CBD Oil And CBD Consumer Health Market

34. Recent Developments In The CBD Oil And CBD Consumer Health Market

35. CBD Oil And CBD Consumer Health Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기